DDX5 AND ASSOCIATED NON-CODING RNAs AND MODULATION OF TH17 EFFECTOR FUNCTION
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jan 19, 2017
app pub date -
May 26, 2016
filing date -
May 29, 2015
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Methods for screening to identify agents capable of modulating DDX5 polypeptide activity are encompassed herein as are methods for using such agents to treat subjects afflicted with TH17-mediated inflammatory conditions and autoimmune diseases including, without limitation, Crohn's disease, ulcerative colitis, multiple sclerosis, rheumatoid arthritis, and psoriasis and methods for using such agents to treat subjects afflicted with cancer.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully